SCHEMBL97503

SCHEMBL97503

O=C(CCS)OCCCCOC(=O)CCS

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 1/20 0.43
DGKA P23743 1/20 0.43
HTR2C P28335 1/20 0.42
ADRA2A P08913 1/20 0.41
ADRA1A P35348 1/20 0.41
DNM1 Q05193 1/20 0.39
MAPT P10636 1/20 0.39
BLM P54132 1/20 0.39
PRSS1 P07477 1/20 0.38
PRSS2 P07478 1/20 0.38
PRSS3 P35030 1/20 0.38
FNTA P49354 1/20 0.37
FNTB P49356 1/20 0.37
RAD52 P43351 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
ALDH1A1 P00352 1/20 0.36
CYP3A4 P08684 1/20 0.36
TSHR P16473 1/20 0.36
TDP1 Q9NUW8 1/20 0.35
FAAH O00519 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL98896 0.97 NAAA (0.46) NAAADGKAHTR2CADRA2AADRA1A
SCHEMBL6599291 0.97 NAAA (0.46) NAAADGKAHTR2CADRA2AADRA1A
SCHEMBL6602344 0.97 NAAA (0.46) NAAADGKAHTR2CADRA2AADRA1A
SCHEMBL98181 0.97 NAAA (0.46) NAAADGKAHTR2CADRA2AADRA1A
SCHEMBL98936 0.97 NAAA (0.46) NAAADGKAHTR2CADRA2AADRA1A
SCHEMBL6603463 0.97 NAAA (0.46) NAAADGKAHTR2CADRA2AADRA1A
SCHEMBL3516908 0.95 FOLH1 (0.42) NAAADGKAHTR2CADRA2AADRA1A
SCHEMBL99058 0.95 DGKA (0.43) NAAADGKAHTR2CADRA2AADRA1A
SCHEMBL3520057 0.93 NAAA (0.43) NAAADGKAHTR2CADRA2AADRA1A
SCHEMBL3516269 0.92 DGKA (0.41) NAAADGKAHTR2CADRA2AADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 866 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4747295-A1 OPTICAL MATERIAL DERIVED FROM A PREPOLYMER OBTAINED FROM A HETERODIFUNCTIONAL ALKYNE COMPOUND ESSILOR INTERNATIONAL (FR) 2026-05-27 EP claimed
EP-4747294-A1 OPTICAL MATERIAL DERIVED FROM A POLYMERIZABLE COMPOSITION CONTAINING A HETERODIFUNCTIONAL ALKYNE COMPOUND Essilor International (FR) 2026-05-27 EP claimed
EP-4747293-A1 OPTICAL MATERIAL DERIVED FROM A POLYMERIZABLE COMPOSITION CONTAINING A TERMINAL DIALKYNE COMPOUND ESSILOR INTERNATIONAL (FR) 2026-05-27 EP claimed
US-20260133459-A1 LOW-TEMPERATURE SOLID POLYMER ELECTROLYTE FOR ELECTROCHROMIC DEVICES LANNRAY ADVANCED MAT CO LTD (CN) 2026-05-14 US claimed
EP-4495639-B1 OPTICAL MATERIAL DERIVED FROM A POLYMERIZABLE COMPOSITION CONTAINING TERMINAL ALKYNE AND THIOL FUNCTIONS ESSILOR INT (FR) 2026-01-21 EP claimed
EP-4642651-A1 PHOSPHINE OXIDE-BASED PHOTOINITIATORS ARKEMA France (FR) 2025-11-05 EP claimed
EP-3275911-B1 POLYMERIZABLE COMPOSITION, OPTICAL MEMBER, PLASTIC LENS, AND EYEGLASS LENS HOYA LENS THAILAND LTD (TH) 2025-07-02 EP claimed
CN-119511594-A Low-temperature solid polymer electrolyte for electrochromic device 览锐新材料(宁波)有限公司 2025-02-25 CN claimed
WO-2025017201-A1 OPTICAL MATERIAL DERIVED FROM A POLYMERIZABLE COMPOSITION CONTAINING A TERMINAL DIALKYNE COMPOUND ESSILOR INTERNATIONAL (FR) 2025-01-23 WO claimed
WO-2025017198-A1 OPTICAL MATERIAL DERIVED FROM A PREPOLYMER OBTAINED FROM A HETERODIFUNCTIONAL ALKYNE COMPOUND ESSILOR INTERNATIONAL (FR) 2025-01-23 WO claimed
EP-2848641-B1 METHOD FOR PRODUCING RUBBER MOLDING NICHIAS CORP (JP) 2018-02-28 EP claimed
EP-3275911-A1 POLYMERIZABLE COMPOSITION, OPTICAL MEMBER, PLASTIC LENS, AND EYEGLASS LENS Hoya Lens Thailand Ltd. (TH) 2018-01-31 EP claimed
US-9527948-B2 Polymerizable composition, optical article obtained therefrom and method for the production of said optical article MITSUI CHEMICALS, INC. (JP) 2016-12-27 US claimed
US-20160000484-A1 COMPOSITION FOR THE TREATMENT OF A BONE FRACTURE REPAIR TECHNOLOGIES SWEDEN AB (SE) 2016-01-07 US claimed
US-20150148495-A1 METHOD FOR PRODUCING RUBBER MOLDING NICHIAS CORPORATION (JP) 2015-05-28 US claimed
EP-2848641-A1 METHOD FOR PRODUCING RUBBER MOLDING Nichias Corporation (JP) 2015-03-18 EP claimed
US-20120308532-A1 COMPOSITION FOR THE TREATMENT OF A BONE FRACTURE PROPPABORT AB (SE) 2012-12-06 US claimed
WO-2011048077-A2 COMPOSITION FOR THE TREATMENT OF A BONE FRACTURE REPAIR TECHNOLOGIES SWEDEN AB (SE) 2011-04-28 WO claimed
US-7268197-B2 Water- and oil-repellent fluorourethanes and fluoroureas 3M INNOVATIVE PROPERTIES COMPANY (US) 2007-09-11 US claimed
US-6117923-A OXIDATION RESISTANCE. POLYMERIZING A NOVEL SULFUR-CONTAINING COMPOUND HAVING AN EPISULFIDE STRUCTURE MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2000-09-12 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260133459-A1 LOW-TEMPERATURE SOLID POLYMER ELECTROLYTE FOR ELECTROCHROMIC DEVICES EEF2, PHF2, EIF4E NAAA 3599/4885DGKA 2877/4885HTR2C 3246/4885
US-20120308532-A1 COMPOSITION FOR THE TREATMENT OF A BONE FRACTURE VCL, BMP2, SHC1 NAAA 4671/4885DGKA 3196/4885HTR2C 4768/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.